Exome Asset Management’s AbCellera Biologics ABCL Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-514,900	Closed	-$1.52M	–	60
2024 Q2	$1.52M	Buy	+514,900	New	+$1.52M	1.36%	32